Search results
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
Benzinga via Yahoo Finance· 2 years agoRoche Holdings AG (OTC: RHHBY) has launched the Elecsys HCV Duo immunoassay, the first available...
Roche launches dual antigen and antibody diagnostic test for hepatitis c
Reuters via Yahoo News· 2 years agoZURICH (Reuters) - Roche has launched an new dual antigen and antibody diagnostic test for hepatitis...
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
Benzinga via Yahoo Finance· 2 years agoRoche Holdings AG (OTC: RHHBY) has announced the launch of its next-generation portfolio of COVID-19...
Roche's (RHHBY) Q1 Sales Grow on COVID-19 Tests, New Drugs
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY performance in the first quarter of 2022 was good on...
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
Investor's Business Daily· 1 year agoRoche said its experimental Alzheimer's treatment failed in two final-phase tests, leading Biogen...
Roche warns 2023 profits will fall on $5 billion COVID sales hit
Reuters via Yahoo Finance· 1 year agoRoche warned on Thursday profits will decline in 2023 as falling demand for its COVID-19 therapy and...
Roche wins FDA approval for first molecular malaria blood donor screening test
MedTech Dive via Yahoo Finance· 4 weeks agoDive Brief: Roche has received Food and Drug Administration approval for the first molecular test to...
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 12 months agoSwiss pharma giant Roche Holding AG’s RHHBY first-quarter revenues declined 7% to CHF 15.3 billion...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
Zacks via Yahoo Finance· 6 months agoRoche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales...